Generic Glyburide and Metformin

Generic Glyburide and Metformin: An Overview

Glyburide and metformin (Glucovance^®) is a prescription medication that has been licensed as a type 2 diabetes treatment. It is a combination medication containing glyburide (DiaBeta^®, Glynase^®, or Micronase^®) and metformin hydrochloride (Fortamet^®, Glucophage^®, Glucophage XR^®, Glumetza^®, or Riomet^®).

 

Glyburide and metformin is manufactured by Bristol-Myers Squibb Company. It is currently under the protection of a patent that prevents any generic glyburide and metformin from being manufactured in the United States. Yet, if you search the Internet for "generic glyburide and metformin," you may find a number of companies selling it. The fact is that these medicines are fake, substandard, and potentially dangerous. There may be generic glyburide and metformin available from another country, but there is really no way of knowing whether or not you are getting genuine glyburide and metformin. You should not buy any generic glyburide and metformin until there is an approved generic available.

 

When Will Generic Glyburide and Metformin Be Available?

The first patent for glyburide and metformin currently expires in 2020. This is the earliest possible date that a generic version of glyburide and metformin could become available. However, there are other circumstances that could come up to extend the exclusivity period of glyburide and metformin beyond 2020. These circumstances could include things such as other patents for specific glyburide and metformin uses or lawsuits. Once glyburide and metformin goes off patent, there may be several companies that manufacture a generic glyburide and metformin drug.